Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of M... Intraday Stock... ...
http://in.advfn.com/p.php?pid=nmona&article=57663084company, today announced that NYSE Technologies, the commercial technology unit of NYSE Euronext (NYX), has extended its global trading network... ...
http://www.presstrust.com/node/1608273Business Services today announced the expansion of Flexible Computing, an Infrastructure as a Service offer. With 500 customers already operating... ...
http://www.presstrust.com/node/1608269NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN · Publication of preliminary annual figures... ...
http://andhranews.net/Business/2013/Imtech-publishes-preliminary-annual-figures-2012-22117.htm/PRNewswire/ --Sanofi (EURONEXT: SANand NYSE: SNY) announced today that the pivotal study, JAKARTA, examining the selective JAK2 inhibitor... ...
http://in.advfn.com/p.php?pid=nmona&article=57622841